The TB epidemic from 1992 to 2002.

[1]  Christopher Dye,et al.  The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. , 2003, Archives of internal medicine.

[2]  C. Dye,et al.  Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru , 2002, The Lancet.

[3]  K. Floyd,et al.  Resources Required for Global Tuberculosis Control , 2002, Science.

[4]  MC Raviglione,et al.  Evolution of WHO policies for tuberculosis control, 1948–2001 , 2002, The Lancet.

[5]  Vikram Pathania,et al.  Private practitioners and public health: weak links in tuberculosis control , 2001, The Lancet.

[6]  C. Dye,et al.  The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru. , 2001, The Journal of infectious diseases.

[7]  Christopher Dye,et al.  Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. , 2001, The New England journal of medicine.

[8]  Jim Whitman.  The Politics of Emerging and Resurgent Infectious Diseases , 2000 .

[9]  C. Dye,et al.  Evaluating the impact of tuberculosis control: number of deaths prevented by short-course chemotherapy in China. , 2000, International journal of epidemiology.

[10]  K. Klaudt.  The Political Causes and Solutions of the Current Tuberculosis Epidemic , 2000 .

[11]  D. Maher,et al.  Community contribution to tuberculosis care in countries with high tuberculosis prevalence: past, present and future. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[12]  C. Dye,et al.  Rational 'DOTS plus' for the control of MDR-TB. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[13]  H L Rieder,et al.  Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. , 1998, The New England journal of medicine.

[14]  P. Chaulet.  After health sector reform, whither lung health? , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[15]  Christopher Dye,et al.  Assessment of worldwide tuberculosis control , 1997, The Lancet.

[16]  D. Enarson,et al.  Successful management of a national tuberculosis programme under conditions of war. , 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[17]  Christopher J. L. Murray.  Results of directly observed short-course chemotherapy in 112 842 Chinese patients with smear-positive tuberculosis , 1996, The Lancet.

[18]  T. Frieden,et al.  Tuberculosis in New York City--turning the tide. , 1995, The New England journal of medicine.

[19]  I. Onorato,et al.  The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. , 1995, The New England journal of medicine.

[20]  D. Enarson.  The International Union Against Tuberculosis and Lung Disease model National Tuberculosis Programmes. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[21]  P. Graf.  Framework for effective tuberculosis control , 1994 .

[22]  Dean T. Jamison,et al.  World development report 1993 : investing in health , 1993 .

[23]  T. Frieden,et al.  The emergence of drug-resistant tuberculosis in New York City. , 1993, The New England journal of medicine.

[24]  M. Raviglione,et al.  Secular trends of tuberculosis in western Europe. , 1993, Bulletin of the World Health Organization.

[25]  A. Kochi,et al.  Tuberculosis: a global overview of the situation today. , 1992, Bulletin of the World Health Organization.

[26]  A. Rouillon.  The Mutual Assistance Programme of the IUATLD. Development, contribution and significance. , 1991, Bulletin of the International Union against Tuberculosis and Lung Disease.

[27]  C. Murray,et al.  Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries , 1991, The Lancet.

[28]  L. Reichman.  The U-shaped curve of concern. , 1991, American Review of Respiratory Disease.

[29]  K. Brudney,et al.  Resurgent Tuberculosis in New York City: Human Immunodeficiency Virus, Homelessness, and the Decline of Tuberculosis Control Programs , 1991, The American review of respiratory disease.

[30]  A. Pozniak,et al.  Is Africa lost? , 1991, The Lancet.

[31]  A. Kochi,et al.  The global tuberculosis situation and the new control strategy of the World Health Organization. , 1991, Tubercle.

[32]  Michael P. Todaro,et al.  World Development Report 1990. , 1990 .

[33]  C. Murray,et al.  Tuberculosis in developing countries: burden, intervention and cost. , 1990, Bulletin of the International Union against Tuberculosis and Lung Disease.

[34]  D. Snider,et al.  Epidemiology of tuberculosis in the United States. , 1989, Epidemiologic reviews.

[35]  K. Stýblo,et al.  Overview and epidemiologic assessment of the current global tuberculosis situation with an emphasis on control in developing countries. , 1989, Reviews of infectious diseases.

[36]  R. W. Mccollum.  Report of a Conference , 1969 .